Invertebrate vaccine science has crossed a commercial threshold: Dalan Animal Health’s United States Department of ...
AbbVie today announced topline results from the Phase 3 EPCORE DLBCL-4 trial evaluating the combination of epcoritamab, a T-cell engaging bispecific antibody, and lenalidomide, compared to rituximab ...
Anivive Lifesciences today announced that the U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine has ...
In a landmark judgment, the apex court reaffirmed that footpaths belong fundamentally to the people and that the right to ...
AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the ...
Upcoming Type B Statistical Methods Meeting expected to set stage for FDA to align with EMA and MHRA on use of Fall 2026 ...
Morning Overview on MSN
Mechanics still name the Camry their default pick to cruise past 250,000 miles
Toyota Camry owners who keep up with routine maintenance and stay current on safety recalls have a measurably better shot at ...
Consistent implementation, accompanied by sustained international pressure, may create a historic opportunity to strengthen the Lebanese state, weaken Hezbollah, and improve regional security and ...
Idaho Public Press on MSNOpinion
Europe’s trust in America is breaking
The transatlantic split is no longer just a fight over NATO bills or trade. Europe is now questioning whether the U.S. can ...
AlzeCure licensed NeuroRestore ACD856 to QuantumCell in a deal worth over $2.2B. The real story is not proof, but Alzheimer’s ...
For those trapped in rubble after an earthquake, survival depends on many factors, including weather and access to water and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results